Modified liujunzi decoction (六君子汤) alleviates chemotherapy-induced anorexia in advanced non-small cell lung cancer: a propensity score matched case-control …
… that received CHM had a low incidence of leucopenia, and particularly experienced less …
for treating all patients intending to receive cisplatin-based chemotherapy and at high risk of …
for treating all patients intending to receive cisplatin-based chemotherapy and at high risk of …
台大醫院非小細胞肺癌病患使用Docetaxel (Taxotere) 每週給藥作為後線化學治療之迴溯性分析研究
羅英 - 2004 - airitilibrary.com
… was demonstrated in patients of non-small cell lung cancer, … A total of 155 patients with
previously treated NSCLC … or neutropenia were predicted by initial dose, leukopenia in previous …
previously treated NSCLC … or neutropenia were predicted by initial dose, leukopenia in previous …
[HTML][HTML] 培美曲塞联合顺铂对比吉西他滨联合顺铂一线治疗晚期非鳞非小细胞肺癌的随机、 对照、 多中心临床研究
黄岩， 刘云鹏， 周建英， 徐农， 李宝兰… - … of Lung Cancer, 2012 - ncbi.nlm.nih.gov
… is still the standard first-line treatment for non-small cell lung cancer (NSCLC). Previous studies
… The main side effects included leukopenia, neutropenia, emesis, anemia, thrombopenia. …
… The main side effects included leukopenia, neutropenia, emesis, anemia, thrombopenia. …
培美曲塞联合铂类一线治疗晚期非鳞非小细胞肺癌的临床观察
陈文怡， 王韡旻， 姜丽岩， 施春雷， 熊丽纹… - 中国癌症 …, 2014 - china-oncology.com
… The patients treated with pemetrexed plus cisplatin, the ORR … The major adverse effects were
leukopenia, neutropenia, … patients with advanced non-small cell lung cancer: a risk-benefit …
leukopenia, neutropenia, … patients with advanced non-small cell lung cancer: a risk-benefit …
台大醫院非小細胞肺癌病患使用Docetaxel (Taxotere) 每週給藥作為後線化學治療之迴溯性分析研究
Y Lo - 2004 - ntur.lib.ntu.edu.tw
… was demonstrated in patients of non-small cell lung cancer, … A total of 155 patients with
previously treated NSCLC … or neutropenia were predicted by initial dose, leukopenia in previous …
previously treated NSCLC … or neutropenia were predicted by initial dose, leukopenia in previous …
RAD23B 基因rs10759225 位点多态性与含铂类方案治疗非小细胞肺癌疗效和血液学毒性的关系
谢晓楠， 文贻勇， 凌琼颖， 黄文锋， 覃芳卉， 王洪学… - 中国癌症防治 …, 2019 - zgazfz.com
… line treatment in patients with advanced non鄄small cell lung … an allele was each associated
with grade 芋/郁of neutropenia … rs10759225 polymorphism and degree of leukopenia[n(%)] …
with grade 芋/郁of neutropenia … rs10759225 polymorphism and degree of leukopenia[n(%)] …
[HTML][HTML] 75 岁以上癌症患者免疫治疗相关不良反应的回顾性分析
陆嘉宁， 马佩， 高雯， 束永前 - 南京医科大学学报(自然科学版), 2023 - jnmu.njmu.edu.cn
… docetaxel in previously treated non ⁃ small ⁃cell lung cancer[J]… inhibitors for treatment
of non ⁃ small cell lung cancer[J].… anemia(78.9%),leucopenia(28.9%),neutropenia(18.7%),…
of non ⁃ small cell lung cancer[J].… anemia(78.9%),leucopenia(28.9%),neutropenia(18.7%),…
[PDF][PDF] 铂类联合紫杉类治疗进展期NSCLC 的
朱柠， 何剑， 张斯为， 陈小东 - scholar.archive.org
… on Treating Advanced Non-small Cell Lung Cancer … words “non small cell lung cancer” or
“Carcinoma, Non Small Cell … The incidence rate of grade 3-4 leukopenia, neutropenia and …
“Carcinoma, Non Small Cell … The incidence rate of grade 3-4 leukopenia, neutropenia and …
Pemetrexed 引起血液副作用之相關影響因素探討
王美廸， 陳怡樺 - 臺灣臨床藥學雜誌, 2020 - airitilibrary.com
… and non-small cell lung cancer (NSCLC) with nonsquamous histology. Pemetrexed can induce
some hematological toxicities, including fatigue, neutropenia… investigated patients treated …
some hematological toxicities, including fatigue, neutropenia… investigated patients treated …
[HTML][HTML] 培美曲塞联合铂类对比吉西他滨联合铂类治疗晚期非小细胞肺癌的meta 分析
姜金， 李伦， 王晓晶， 田金徽， 王权… - … Journal of Lung Cancer, 2011 - ncbi.nlm.nih.gov
… for patients with advanced non-small cell lung cancer (NSCLC) is unclear. The aim of this
study is to evaluate the efcacy and safety of PP versus GP regimens for patients with NSCLC. …
study is to evaluate the efcacy and safety of PP versus GP regimens for patients with NSCLC. …